Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine.
about
Progress towards recombinant anti-infective antibodies.Substitution at aspartic acid 1128 in the SARS coronavirus spike glycoprotein mediates escape from a S2 domain-targeting neutralizing monoclonal antibodyThe Hemagglutinin Stem-Binding Monoclonal Antibody VIS410 Controls Influenza Virus-Induced Acute Respiratory Distress Syndrome.
P2860
Severe acute respiratory syndrome (SARS) coronavirus: application of monoclonal antibodies and development of an effective vaccine.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Severe acute respiratory syndr ...... pment of an effective vaccine.
@ast
Severe acute respiratory syndr ...... pment of an effective vaccine.
@en
type
label
Severe acute respiratory syndr ...... pment of an effective vaccine.
@ast
Severe acute respiratory syndr ...... pment of an effective vaccine.
@en
prefLabel
Severe acute respiratory syndr ...... pment of an effective vaccine.
@ast
Severe acute respiratory syndr ...... pment of an effective vaccine.
@en
P2093
P2860
P356
P1476
Severe acute respiratory syndr ...... pment of an effective vaccine.
@en
P2093
Kazuo Ohnishi
Toshitada Takemori
Yasuko Tsunetsugu-Yokota
P2860
P304
P356
10.1002/RMV.492
P577
2006-03-01T00:00:00Z